Literature DB >> 11843688

Refractory status epilepticus in 2001.

Thomas P Bleck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11843688     DOI： 10.1001/archneur.59.2.188

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  9 in total

1.  CSF-air-exchange for pharmacorefractory status epilepticus.

Authors:  Martin Köhrmann; Hagen B Huttner; Daniel Gotthardt; Simon Nagel; Christian Berger; Stefan Schwab
Journal:  J Neurol       Date:  2006-04-11       Impact factor: 4.849

2.  Prolonged coma from refractory status epilepticus.

Authors:  Saqib I Dara; Lori A Tungpalan; Edward M Manno; Vivien H Lee; Kevin G Moder; Mark T Keegan; Jimmy R Fulgham; Daniel R Brown; Keith H Berge; Francis X Whalen; Tuhin K Roy
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

3.  Treatment of pediatric refractory status epilepticus with topiramate.

Authors:  Başak Nur Akyildiz; Sefer Kumandaş
Journal:  Childs Nerv Syst       Date:  2011-03-26       Impact factor: 1.475

4.  Diagnosis and Treatment of Nonconvulsive Status Epilepticus in an Intensive Care Unit Setting.

Authors:  Stephan J. Rüegg; Marc A. Dichter
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

Review 5.  Recent developments in the diagnosis and treatment of status epilepticus.

Authors:  Megan Selvitelli; Frank W Drislane
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

6.  Status epilepticus.

Authors:  Ajith Cherian; Sanjeev V Thomas
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

Review 7.  Literature review, case report, and expert discussion of prolonged refractory status epilepticus.

Authors:  T K Robakis; L J Hirsch
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

8.  Status epilepticus: current treatment strategies.

Authors:  Edward M Manno
Journal:  Neurohospitalist       Date:  2011-01

9.  Prognostic factors of status epilepticus in children.

Authors:  Du Cheol Kang; Young-Mock Lee; JoonSoo Lee; Heung Dong Kim; ChangJun Coe
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.